{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:59:55Z","timestamp":1786978795536,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":7,"publisher":"Springer US","isbn-type":[{"value":"9781071635407","type":"print"},{"value":"9781071635414","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3541-4_5","type":"book-chapter","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T19:27:05Z","timestamp":1701372425000},"page":"43-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Quantitative LC-MS\/MS Method for the Simultaneous Measurement of Six Antiepileptics and Pentobarbital in Human Serum"],"prefix":"10.1007","author":[{"given":"Geza S.","family":"Bodor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Rands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"37","key":"5_CR1","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.2174\/1381612823666170926103631","volume":"23","author":"LR Pisani","year":"2017","unstructured":"Pisani LR, Nikanorova M, Landmark CJ, Johannessen SI, Pisani F (2017) Specific patient features affect antiepileptic drug therapy decisions: focus on gender, age, and psychiatric comorbidities. Curr Pharm Des 23(37):5639\u20135648","journal-title":"Curr Pharm Des"},{"issue":"11","key":"5_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","volume":"45","author":"SI Johannessen","year":"2006","unstructured":"Johannessen SI, Tomson T (2006) Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? Clin Pharmacokinet 45(11):1061\u20131075","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"5_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.2174\/157015910792246254","volume":"8","author":"SI Johannessen","year":"2010","unstructured":"Johannessen SI, Landmark CJ (2010) Antiepileptic drug interactions \u2013 principles and clinical implications. Curr Neuropharmacol 8(3):254\u2013267","journal-title":"Curr Neuropharmacol"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/DDDT.S154388","volume":"12","author":"A Reimers","year":"2018","unstructured":"Reimers A, Berg JA, Burns ML, Brodtkorb E, Johannessen SI, Johannessen Landmark C (2018) Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines. Drug Des Devel Ther 12:271\u2013280","journal-title":"Drug Des Devel Ther"},{"issue":"7","key":"5_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BF, Cloyd JC, Glauser TA, Johannessen SI et al (2008) Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49(7):1239\u20131276","journal-title":"Epilepsia"},{"issue":"12","key":"5_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.5858\/arpa.2020-0562-CP","volume":"145","author":"MD Krasowski","year":"2021","unstructured":"Krasowski MD, Long TA, Snozek CLH, Dizon A, Magnani B, Melanson SEF (2021) Therapeutic drug monitoring of second- and third-generation antiepileptic drugs. Arch Pathol Lab Med 145(12):1485\u20131491","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"5_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/17425255.2020.1724956","volume":"16","author":"C Johannessen Landmark","year":"2020","unstructured":"Johannessen Landmark C, Johannessen SI, Patsalos PN (2020) Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects. Expert Opin Drug Metab Toxicol 16(3):227\u2013238","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3541-4_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T19:32:02Z","timestamp":1701372722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3541-4_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"ISBN":["9781071635407","9781071635414"],"references-count":7,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3541-4_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"1 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}